The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial
NCT03889314
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Cardiovascular Risk Factor
Cardiovascular Diseases
Adverse Effect
Interventions
DRUG:
Rosuvastatin 20mg
OTHER:
Placebo
Sponsor
Minneapolis Heart Institute Foundation